[1] Marr JE, Drake-Lee A, Willshaw HE. Management of children epiphora[J]. Br J Ophthalmol, 2005,89(9):1123-1126. [2] Casady DR, Meyer DR, Simon JW, et al. Stepwise treatment paradigm for congenital nasolacrimal duct obstruction[J]. Ophthal Plast and Reconstr Surq, 2006, 22(4):243-247. [3] 杨晨皓,高路,汪芳润.先天性鼻泪管阻塞治疗探讨[J].中国实用眼科杂志,2008,26(9):1000-1002. [4] 张颜芳,张慧文,王美娟.新生儿泪囊炎的早期治疗[J].中国儿童保健杂志,2009,17(2):245-246. [5] 华宁,马文江,汪建涛,等.1至4个月龄正常婴幼儿结膜囊菌群分布特征分析[J].中华眼科杂志,2010,46(6):537-541. [6] 孙红,赵江月,阎启昌,等.婴幼儿泪囊炎致病菌分布和药物敏感性分析[J].中华眼科杂志,2010,46(1):34-37. [7] 毛海燕,符惠群,陈和琴,等.先天性泪囊炎病原菌培养及药物敏感性分析[J].中国眼耳鼻喉科杂志,2008,8(2):109-112. [8] 孙先桃,陈敏,卢跃兵.新生儿泪囊炎细菌培养及药敏结果分析[J].山东医药,2006,46(30):36-37. [9] Usha K, Smitha S, Shah N, et al. Spectrum and the susceptibilities of microbial isolates in cases of congenital nasolacrimal duct obstruction[J]. JAAPOS,2006,10(5):469-472. [10] Haas J, Larson E, Ross B, et al. Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients[J]. Pediatr Infect Dis J,2005,24(7):586-589. |